SAREPTA THERAPEUTICS INC
SRPTNASDAQ🏆 #2059 by market capEarnings Feb 23 · PostUS Equity
$13.33▼ $0.84 (−5.93%)
Market closed · at closeTrack SRPT
Get earnings, price moves & breaking news on Telegram
24h▼ 5.9%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1.41B
Small Cap
📈Revenue Growth (YoY)
-18.9%
Declining
📊Gross Margin
65.2%
High
💵FCF Margin
19.3%
Healthy
⚖️P/S Ratio
0.7x
Cheap
Otter Score
72
Strong
SAREPTA THERAPEUTICS INC
SRPTAnalyst Ratings
Price
$13.33
Total
55
Raised
6
Lowered
8
Avg PT
$21.40
H / L
$27 / $17
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Sector Perform | 2026-11-06 | $17.00 | +27.50% |
HC Wainwright & Co. | Reiterated | Sell | 2026-10-05 | — | — |
JP Morgan | Reiterated | Neutral | 2026-09-30 | — | — |
Needham | Reiterated | Underperform | 2026-09-28 | $202.00 | +1415.40% |
Piper Sandler | Reiterated | Neutral | 2026-07-09 | $20.00 | +50.00% |
Wolfe Research | Upgraded | Peer Perform → Outperform | 2026-07-09 | $27.00 | +102.60% |
Citigroup | Reiterated | Sell | 2026-03-26 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-03-19 | $180.00 | +1250.30% |
Mizuho | Reiterated | Outperform | 2026-03-13 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-02-27 | $75.00 | +462.60% |
Wedbush | Reiterated | Outperform | 2026-01-23 | $35.00 | +162.60% |
Guggenheim | Reiterated | Buy | 2025-11-05 | — | — |
Barclays | Reiterated | Equal Weight | 2025-11-05 | $20.00 | +50.00% |
Baird | Reiterated | Neutral | 2025-11-04 | — | — |
BMO Capital | Upgraded | Market Perform → Outperform | 2025-09-22 | $50.00 | +275.10% |
Leerink Partners | Reiterated | Market Perform | 2025-09-09 | $15.00 | +12.50% |
B of A Securities | Reiterated | Underperform | 2025-08-21 | — | — |
Deutsche Bank | Reiterated | Sell | 2025-08-15 | $14.00 | +5.00% |
Goldman Sachs | Reiterated | Neutral | 2025-08-07 | $155.00 | +1062.80% |
Morgan Stanley | Reiterated | Equal Weight | 2025-07-29 | $25.00 | +87.50% |
Jefferies | Reiterated | Buy | 2025-07-24 | $30.00 | +125.10% |
Leerink Swann | Downgraded | Outperform → Market Perform | 2025-07-21 | — | — |
UBS | Downgraded | Buy → Neutral | 2025-07-21 | $158.00 | +1085.30% |
William Blair | Downgraded | Outperform → Market Perform | 2025-06-20 | — | — |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2025-06-06 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2025-05-07 | $20.00 | +50.00% |
Evercore ISI Group | Reiterated | Outperform | 2024-11-07 | — | — |
Credit Suisse | Reiterated | Neutral | 2023-06-23 | $114.00 | +755.20% |
SMBC Nikko | Reiterated | Outperform | 2023-04-26 | — | — |
TD Cowen | Reiterated | Outperform | 2023-03-22 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-20 | — | — |
BTIG | Reiterated | Buy | 2022-12-22 | $160.00 | +1100.30% |
Raymond James | Downgraded | Outperform → Market Perform | 2021-01-08 | — | — |
Berenberg | Reiterated | Hold | 2020-11-11 | — | — |
Janney Capital | Reiterated | Buy | 2019-12-13 | — | — |
PiperJaffray | Reiterated | Overweight | 2019-12-13 | — | — |
Janney Montgomery Scott | Reiterated | Buy | 2019-12-13 | — | — |
Citi | Reiterated | Buy | 2019-11-18 | — | — |
Guggenheim Securities | Reiterated | Buy | 2019-11-01 | — | — |
Bank of America | Reiterated | Buy | 2019-08-20 | — | — |
Nomura | Reiterated | Buy | 2019-02-28 | — | — |
Bernstein | Reiterated | Outperform | 2018-10-12 | $20.00 | +50.00% |
H.C. Wainwright | Reiterated | Buy | 2018-06-19 | $10.00 | −25.00% |
BTIG Research | Reiterated | Buy | 2018-06-15 | — | — |
SunTrust Robinson Humphrey | Upgraded | Hold → Buy | 2017-04-05 | — | — |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2016-09-20 | — | — |
JMP Securities | Downgraded | Market Perform → Underperform | 2016-03-23 | — | — |
Roth Capital | Reiterated | Buy | 2015-08-26 | — | — |
Canaccord Genuity | Upgraded | Hold → Buy | 2015-05-20 | — | — |
Stifel Nicolaus | Downgraded | Buy → Hold | 2014-10-27 | — | — |
Stifel | Downgraded | Buy → Hold | 2014-10-27 | — | — |
WBB Securities | Reiterated | Speculative Buy → Buy | 2014-07-29 | — | — |
Burrill & Company | Downgraded | Market Outperform → Market Perform | 2013-07-24 | — | — |
Dawson James | Reiterated | Market Perform → Perform | 2012-11-27 | — | — |
ThinkEquity | Reiterated | Buy | 2012-08-27 | — | — |
Institution
RBC Capital
Reiterated · Sector Perform · 2026-11-06
$17.00
+27.50%
HC Wainwright & Co.
Reiterated · Sell · 2026-10-05
—
—
JP Morgan
Reiterated · Neutral · 2026-09-30
—
—
Needham
Reiterated · Underperform · 2026-09-28
$202.00
+1415.40%
Piper Sandler
Reiterated · Neutral · 2026-07-09
$20.00
+50.00%
Wolfe Research
Upgraded · Peer Perform → Outperform · 2026-07-09
$27.00
+102.60%
Citigroup
Reiterated · Sell · 2026-03-26
—
—
Oppenheimer
Reiterated · Outperform · 2026-03-19
$180.00
+1250.30%
Mizuho
Reiterated · Outperform · 2026-03-13
—
—
Wells Fargo
Reiterated · Overweight · 2026-02-27
$75.00
+462.60%
Wedbush
Reiterated · Outperform · 2026-01-23
$35.00
+162.60%
Guggenheim
Reiterated · Buy · 2025-11-05
—
—
Barclays
Reiterated · Equal Weight · 2025-11-05
$20.00
+50.00%
Baird
Reiterated · Neutral · 2025-11-04
—
—
BMO Capital
Upgraded · Market Perform → Outperform · 2025-09-22
$50.00
+275.10%
Leerink Partners
Reiterated · Market Perform · 2025-09-09
$15.00
+12.50%
B of A Securities
Reiterated · Underperform · 2025-08-21
—
—
Deutsche Bank
Reiterated · Sell · 2025-08-15
$14.00
+5.00%
Goldman Sachs
Reiterated · Neutral · 2025-08-07
$155.00
+1062.80%
Morgan Stanley
Reiterated · Equal Weight · 2025-07-29
$25.00
+87.50%
Jefferies
Reiterated · Buy · 2025-07-24
$30.00
+125.10%
Leerink Swann
Downgraded · Outperform → Market Perform · 2025-07-21
—
—
UBS
Downgraded · Buy → Neutral · 2025-07-21
$158.00
+1085.30%
William Blair
Downgraded · Outperform → Market Perform · 2025-06-20
—
—
Scotiabank
Upgraded · Sector Perform → Sector Outperform · 2025-06-06
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2025-05-07
$20.00
+50.00%
Evercore ISI Group
Reiterated · Outperform · 2024-11-07
—
—
Credit Suisse
Reiterated · Neutral · 2023-06-23
$114.00
+755.20%
SMBC Nikko
Reiterated · Outperform · 2023-04-26
—
—
TD Cowen
Reiterated · Outperform · 2023-03-22
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-20
—
—
BTIG
Reiterated · Buy · 2022-12-22
$160.00
+1100.30%
Raymond James
Downgraded · Outperform → Market Perform · 2021-01-08
—
—
Berenberg
Reiterated · Hold · 2020-11-11
—
—
Janney Capital
Reiterated · Buy · 2019-12-13
—
—
PiperJaffray
Reiterated · Overweight · 2019-12-13
—
—
Janney Montgomery Scott
Reiterated · Buy · 2019-12-13
—
—
Citi
Reiterated · Buy · 2019-11-18
—
—
Guggenheim Securities
Reiterated · Buy · 2019-11-01
—
—
Bank of America
Reiterated · Buy · 2019-08-20
—
—
Nomura
Reiterated · Buy · 2019-02-28
—
—
Bernstein
Reiterated · Outperform · 2018-10-12
$20.00
+50.00%
H.C. Wainwright
Reiterated · Buy · 2018-06-19
$10.00
−25.00%
BTIG Research
Reiterated · Buy · 2018-06-15
—
—
SunTrust Robinson Humphrey
Upgraded · Hold → Buy · 2017-04-05
—
—
Cowen & Co.
Upgraded · Market Perform → Outperform · 2016-09-20
—
—
JMP Securities
Downgraded · Market Perform → Underperform · 2016-03-23
—
—
Roth Capital
Reiterated · Buy · 2015-08-26
—
—
Canaccord Genuity
Upgraded · Hold → Buy · 2015-05-20
—
—
Stifel Nicolaus
Downgraded · Buy → Hold · 2014-10-27
—
—
Stifel
Downgraded · Buy → Hold · 2014-10-27
—
—
WBB Securities
Reiterated · Speculative Buy → Buy · 2014-07-29
—
—
Burrill & Company
Downgraded · Market Outperform → Market Perform · 2013-07-24
—
—
Dawson James
Reiterated · Market Perform → Perform · 2012-11-27
—
—
ThinkEquity
Reiterated · Buy · 2012-08-27
—
—
One row per institution · price target from the firm's latest published target